structure-guided design of a selective bcl-x l inhibitor structure-guided design of a selective...
TRANSCRIPT
![Page 1: Structure-guided design of a selective BCL-X L inhibitor Structure-guided design of a selective BCL-X L inhibitor Tianlei Sun 2013/11/26](https://reader036.vdocuments.site/reader036/viewer/2022082612/5697bf711a28abf838c7dd15/html5/thumbnails/1.jpg)
Structure-guided design of Structure-guided design of a selective BCL-Xa selective BCL-XLL
inhibitor inhibitor
Tianlei Sun2013/11/26
![Page 2: Structure-guided design of a selective BCL-X L inhibitor Structure-guided design of a selective BCL-X L inhibitor Tianlei Sun 2013/11/26](https://reader036.vdocuments.site/reader036/viewer/2022082612/5697bf711a28abf838c7dd15/html5/thumbnails/2.jpg)
Why search for inhibitors of BCL-XLWhy search for inhibitors of BCL-XL
BCL-XL is anti-apoptotic protein.
Enhancing apoptotic responses of cancer cells by inhibiting BCL-XL.
Instead of inhibiting multiple anti-apoptotic BCL-2 family members, a BCL-XL–selective inhibitor would be expected to minimize the toxicity to normal tissues.
![Page 3: Structure-guided design of a selective BCL-X L inhibitor Structure-guided design of a selective BCL-X L inhibitor Tianlei Sun 2013/11/26](https://reader036.vdocuments.site/reader036/viewer/2022082612/5697bf711a28abf838c7dd15/html5/thumbnails/3.jpg)
How they didHow they didHigh-throughput screen
Fig.1 Compound 1a identified from the screen and close analog 1b
![Page 4: Structure-guided design of a selective BCL-X L inhibitor Structure-guided design of a selective BCL-X L inhibitor Tianlei Sun 2013/11/26](https://reader036.vdocuments.site/reader036/viewer/2022082612/5697bf711a28abf838c7dd15/html5/thumbnails/4.jpg)
Fig.2 Two potential binding modes for 1b in the hydrophobic groove of BCL-XL.
![Page 5: Structure-guided design of a selective BCL-X L inhibitor Structure-guided design of a selective BCL-X L inhibitor Tianlei Sun 2013/11/26](https://reader036.vdocuments.site/reader036/viewer/2022082612/5697bf711a28abf838c7dd15/html5/thumbnails/5.jpg)
Fig.3 Structure of compound2. Fig.4 binding mode of 2 in the BCL-XL hydrophobic groove
Fig.5 interaction network between the benzothiazole moiety of 2 and Ser106, Asp107 and Leu108 in the P2 pocket.
![Page 6: Structure-guided design of a selective BCL-X L inhibitor Structure-guided design of a selective BCL-X L inhibitor Tianlei Sun 2013/11/26](https://reader036.vdocuments.site/reader036/viewer/2022082612/5697bf711a28abf838c7dd15/html5/thumbnails/6.jpg)
Fig.6 Position of Phe105 in relation to the furan moiety of 2 and the electrostatic interaction between Arg139 and the acylsulfonamide group of 2.
![Page 7: Structure-guided design of a selective BCL-X L inhibitor Structure-guided design of a selective BCL-X L inhibitor Tianlei Sun 2013/11/26](https://reader036.vdocuments.site/reader036/viewer/2022082612/5697bf711a28abf838c7dd15/html5/thumbnails/7.jpg)
![Page 8: Structure-guided design of a selective BCL-X L inhibitor Structure-guided design of a selective BCL-X L inhibitor Tianlei Sun 2013/11/26](https://reader036.vdocuments.site/reader036/viewer/2022082612/5697bf711a28abf838c7dd15/html5/thumbnails/8.jpg)
![Page 9: Structure-guided design of a selective BCL-X L inhibitor Structure-guided design of a selective BCL-X L inhibitor Tianlei Sun 2013/11/26](https://reader036.vdocuments.site/reader036/viewer/2022082612/5697bf711a28abf838c7dd15/html5/thumbnails/9.jpg)
PymolPymol 演示演示